{"id":70781,"date":"2026-05-12T11:03:24","date_gmt":"2026-05-12T11:03:24","guid":{"rendered":"https:\/\/medsbase.com\/?post_type=product&#038;p=70781"},"modified":"2026-05-21T07:14:09","modified_gmt":"2026-05-21T07:14:09","slug":"hgh-fragment-176-191","status":"publish","type":"product","link":"https:\/\/medsbase.com\/cs\/product\/hgh-fragment-176-191\/","title":{"rendered":"HGH Fragment 176-191"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background: #fff8e1; border-left: 4px solid #f5a623; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<h3 style=\"margin: 0 0 8px 0; font-size: 16px; color: #1a4a6b;\">Rychl\u00e1 odpov\u011b\u010f \u2014 Co je HGH Fragment 176-191?<\/h3>\n<p style=\"margin: 0;\"><strong>HGH Fragment 176-191<\/strong> je syntetick\u00fd peptid o 16 aminokyselin\u00e1ch odpov\u00eddaj\u00edc\u00ed C-termin\u00e1ln\u00edm zbytk\u016fm 176\u2013191 <a href=\"https:\/\/medsbase.com\/cs\/hgh-191aa\/\">lidsk\u00e9ho r\u016fstov\u00e9ho hormonu<\/a>. Podle publikovan\u00fdch v\u00fdzkum\u016f si zachov\u00e1v\u00e1 lipolytickou (tuk mobilizuj\u00edc\u00ed) a gluk\u00f3zu moduluj\u00edc\u00ed aktivitu mate\u0159sk\u00e9 molekuly HGH, ale postr\u00e1d\u00e1 afinitu k GH receptoru, a proto neaktivuje produkci IGF-1, signalizaci chondrocyt\u016f ani \u017e\u00e1dn\u00e9 z r\u016fst podporuj\u00edc\u00edch \u00fa\u010dink\u016f pln\u00e9 d\u00e9lky HGH. Sekvence: YLRIVQCRSVEGSCGF. Dod\u00e1v\u00e1 se v lyofilizovan\u00fdch vialk\u00e1ch o obsahu 5\u201315 mg pouze pro laboratorn\u00ed v\u00fdzkum.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background: #f4f8fb; border: 1px solid #d8e3eb; padding: 12px 16px; margin: 16px 0; border-radius: 4px; font-size: 14px;\"><strong>Co z\u00edsk\u00e1te s MedsBase:<\/strong> V\u00fdzkumn\u00e9 lyofilizovan\u00e9 peptidy \u00b7 HPLC \u010distota \u226599% (COA na vy\u017e\u00e1d\u00e1n\u00ed) \u00b7 Diskr\u00e9tn\u00ed teplotn\u011b stabiln\u00ed balen\u00ed \u00b7 Celosv\u011btov\u00e1 p\u0159eprava peptid\u016f \u00b7 1,400+ ov\u011b\u0159en\u00fdch <a href=\"https:\/\/medsbase.com\/cs\/reviews\/\">recenz\u00ed z\u00e1kazn\u00edk\u016f<\/a><\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size: 14px; color: #444; margin: 8px 0 18px;\">\ud83d\udce6 Ka\u017ed\u00e1 objedn\u00e1vka je pokryta na\u0161\u00ed <a href=\"https:\/\/medsbase.com\/cs\/medsbase-re-shipment-assurance-policy\/\"><strong>Z\u00e1rukou op\u011btovn\u00e9ho odesl\u00e1n\u00ed<\/strong><\/a> \u2014 pokud va\u0161e z\u00e1silka nedoraz\u00ed do 20 pracovn\u00edch dn\u016f, p\u0159epos\u00edl\u00e1me ji.<\/p>\n<table class=\"medsbase-spec-table\" style=\"width: 100%; border-collapse: collapse; margin: 18px 0; font-size: 14px;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 8px 12px; text-align: left; width: 30%;\">Specifikace<\/th>\n<th style=\"padding: 8px 12px; text-align: left;\">Detail<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>CAS \u010d\u00edslo<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">66004-57-7 (HGH Fragment 176-191; odli\u0161n\u00fd od AOD9604 CAS 221231-10-9)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>item2<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">C<sub>78<\/sub>H<sub>125<\/sub>N<sub>23<\/sub>O<sub>23<\/sub>S<sub>2<\/sub><\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>item7<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">1817.06 Da<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>item9<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe (YLRIVQCRSVEGSCGF, 16 aminokyselin; pozice 176\u2013191 p\u0159irozen\u00e9ho lidsk\u00e9ho r\u016fstov\u00e9ho hormonu, zachov\u00e1vaj\u00edc\u00ed disulfidov\u00fd m\u016fstek Cys182\u2013Cys189 mate\u0159sk\u00e9 molekuly)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>item11<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Lyofilizovan\u00fd pr\u00e1\u0161ek (b\u00edl\u00fd a\u017e sv\u011btle \u017elut\u00fd)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>item13<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u226599% (HPLC ov\u011b\u0159eno, COA na vy\u017e\u00e1d\u00e1n\u00ed)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Skladov\u00e1n\u00ed<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Lyofilizovan\u00e9: 2\u20138 \u00b0C (lednice) pro pracovn\u00ed z\u00e1sobu; \u221220 \u00b0C pro dlouhodob\u00e9 skladov\u00e1n\u00ed neotev\u0159en\u00fdch vialek. Rekonstituovan\u00e9: 2\u20138 \u00b0C, pou\u017eijte do ~30 dn\u016f. Chra\u0148te p\u0159ed sv\u011btlem. Nefreeze\u2013thaw rekonstituovan\u00fd roztok.<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Rozpustnost<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Bakteriostatick\u00e1 voda (doporu\u010deno) nebo steriln\u00ed voda pro krat\u0161\u00ed dobu pou\u017eit\u00ed<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Pouze pro v\u00fdzkum<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Pouze pro laboratorn\u00ed v\u00fdzkum. Nen\u00ed ur\u010deno pro diagnostick\u00e9 nebo terapeutick\u00e9 pou\u017eit\u00ed u lid\u00ed nebo zv\u00ed\u0159at.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><!-- \/medsbase-tldr-answer --><\/p>\n<h2>Co je HGH Fragment 176-191?<\/h2>\n<p><strong>HGH Fragment 176-191<\/strong> je 16-aminokyselinov\u00fd syntetick\u00fd peptid odpov\u00eddaj\u00edc\u00ed C-termin\u00e1ln\u00edm zbytk\u016fm 176 a\u017e 191 p\u0159irozen\u00e9ho lidsk\u00e9ho r\u016fstov\u00e9ho hormonu. Tento fragment byl identifikov\u00e1n b\u011bhem v\u00fdzkumu struktury a funkce HGH prov\u00e1d\u011bn\u00e9ho na Monash University v 90. letech 20. stolet\u00ed, kdy v\u00fdzkumn\u00edci systematicky zkracovali a modifikovali molekulu HGH, aby mapovali oblasti odpov\u011bdn\u00e9 za ka\u017edou z jej\u00edch mnoha biologick\u00fdch aktivit. Uk\u00e1zalo se, \u017ee oblast 176-191 si zachov\u00e1v\u00e1 lipolytickou (tuk mobilizuj\u00edc\u00ed) a antilipogenn\u00ed aktivitu pln\u00e9 d\u00e9lky HGH, zat\u00edmco zcela ztr\u00e1c\u00ed dom\u00e9nu v\u00e1zaj\u00edc\u00ed se na GH receptor, kter\u00e1 se nach\u00e1z\u00ed v N-termin\u00e1ln\u00ed \u010d\u00e1sti mate\u0159sk\u00e9 molekuly.<\/p>\n<p>Dob\u0159e charakterizovan\u00e1 sekvence je YLRIVQCRSVEGSCGF s zachovan\u00fdm p\u0159irozen\u00fdm intramolekul\u00e1rn\u00edm disulfidov\u00fdm m\u016fstkem Cys182\u2013Cys189 (v r\u00e1mci \u010d\u00edslov\u00e1n\u00ed fragmentu se jedn\u00e1 o Cys7\u2013Cys14). Molekulov\u00e1 hmotnost 1817,06 Da, empirick\u00fd vzorec C<sub>78<\/sub>H<sub>125<\/sub>N<sub>23<\/sub>O<sub>23<\/sub>S<sub>2<\/sub>. HGH Fragment 176-191 je struktur\u00e1ln\u011b a farmakologicky <strong>odli\u0161n\u00fd od AOD9604<\/strong> \u2014 analogu vyvinut\u00e9ho spole\u010dnost\u00ed Metabolic Pharmaceuticals, kter\u00fd p\u0159id\u00e1v\u00e1 N-termin\u00e1ln\u00ed tyrosinovou substituci (vytv\u00e1\u0159ej\u00edc\u00ed Tyr-HGH 177-191) a modifikuje disulfidov\u00fd m\u016fstek. AOD9604 m\u00e1 sv\u00e9 vlastn\u00ed CAS (221231-10-9) a farmakologick\u00fd profil a nem\u011bl by b\u00fdt zam\u011b\u0148ov\u00e1n s neupraven\u00fdm fragmentem 176-191 dod\u00e1van\u00fdm zde.<\/p>\n<p>HGH Fragment 176-191 je dod\u00e1v\u00e1n jako vysoce \u010dist\u00fd lyofilizovan\u00fd pr\u00e1\u0161ek pro rekonstituci s bakteriostatickou vodou. Tento fragment nen\u00ed <strong>FDA, EMA, MHRA ani \u017e\u00e1dn\u00fdm jin\u00fdm v\u00fdznamn\u00fdm regul\u00e1torem pro terapeutick\u00e9 pou\u017eit\u00ed u lid\u00ed. V\u00fdzkumn\u00fd DSIP prod\u00e1van\u00fd zde je dod\u00e1v\u00e1n<\/strong> schv\u00e1len FDA, EMA, MHRA ani \u017e\u00e1dn\u00fdm jin\u00fdm v\u00fdznamn\u00fdm regul\u00e1torem pro terapeutick\u00e9 pou\u017eit\u00ed u lid\u00ed. V\u00fdzkumn\u00fd HGH Fragment 176-191 prod\u00e1van\u00fd zde je dod\u00e1v\u00e1n <strong>ur\u010den pouze pro laboratorn\u00ed v\u00fdzkum<\/strong> a nen\u00ed ur\u010den pro pod\u00e1v\u00e1n\u00ed lidem nebo zv\u00ed\u0159at\u016fm. Pro plnou d\u00e9lku mate\u0159sk\u00e9 molekuly viz n\u00e1\u0161 <a href=\"https:\/\/medsbase.com\/cs\/hgh-191aa\/\">HGH 191AA<\/a> produktovou str\u00e1nku.<\/p>\n<h2>Mechanismus \u00fa\u010dinku \u2014 Lipolytick\u00e1 aktivita bez vazby na GH receptor<\/h2>\n<p>Co \u010din\u00ed HGH Fragment 176-191 mechanisticky v\u00fdjime\u010dn\u00fdm, je <strong>odd\u011blen\u00ed lipol\u00fdzy od signalizace r\u016fstov\u00e9 osy<\/strong> \u2014 jeden z nej\u010dist\u0161\u00edch p\u0159\u00edklad\u016f strukturn\u011b-funk\u010dn\u00ed disekce ve v\u00fdzkumu peptidov\u00e9 farmakologie:<\/p>\n<ul>\n<li><strong>Nep\u0159\u00edtomnost vazby na GH receptor<\/strong> \u2014 Povrch v\u00e1zaj\u00edc\u00ed se na GH receptor p\u0159irozen\u00e9ho HGH je obsa\u017een v N-termin\u00e1ln\u00ed \u010d\u00e1sti molekuly (oblast zbytk\u016f 1\u2013120), nikoli v C-termin\u00e1ln\u00edm fragmentu 176\u2013191. V d\u016fsledku toho HGH Fragment 176-191 NEv\u00e1\u017ee se na receptor r\u016fstov\u00e9ho hormonu (GHR), NEaktivuje signalizaci JAK2\/STAT5, NEindukuje produkci jatern\u00edho IGF-1 a NEvyvol\u00e1v\u00e1 \u017e\u00e1dn\u00e9 z r\u016fst podporuj\u00edc\u00edch, chondrocyty stimuluj\u00edc\u00edch nebo inzul\u00edn proti reguluj\u00edc\u00edch \u00fa\u010dink\u016f mate\u0159sk\u00e9 <a href=\"https:\/\/medsbase.com\/cs\/hgh-191aa\/\">HGH 191AA<\/a> molekuly. Toto je definuj\u00edc\u00ed negativn\u00ed farmakologick\u00e1 vlastnost a z\u00e1klad jeho v\u00fdzkumn\u00e9 utility jako n\u00e1stroje pro izolaci lipolytick\u00e9 osy.<\/li>\n<li><strong>Zachovan\u00e1 lipolytick\u00e1 aktivita<\/strong> \u2014 Publikovan\u00fd v\u00fdzkum dokumentuje, \u017ee fragment HGH 176-191 si zachov\u00e1v\u00e1 schopnost mobilizovat tuky jako cel\u00fd HGH molekuly v adipocytech. P\u0159esn\u00fd molekul\u00e1rn\u00ed c\u00edl zodpov\u011bdn\u00fd za lipolytick\u00fd efekt z\u016fst\u00e1v\u00e1 p\u0159edm\u011btem aktivn\u00edho v\u00fdzkumu; navrhovan\u00e9 mechanismy zahrnuj\u00ed p\u0159\u00edm\u00fd \u00fa\u010dinek na beta-3 adrenergn\u00ed receptory adipocyt\u016f, modulaci hormon-senzitivn\u00ed lip\u00e1zy a zm\u011bny kinetiky oxidace mastn\u00fdch kyselin. Lipolytick\u00fd sign\u00e1l je v n\u011bkter\u00fdch publikovan\u00fdch studi\u00edch na hlodavc\u00edch pozorov\u00e1n p\u0159ednostn\u011b ve viscer\u00e1ln\u00edch tukov\u00fdch z\u00e1sob\u00e1ch, co\u017e paraleln\u011b, ale mechanisticky odli\u0161n\u011b koresponduje s <a href=\"https:\/\/medsbase.com\/cs\/tesamorelin\/\">Tesamorelin<\/a> v\u00fdzkumn\u00fdm sign\u00e1lem viscer\u00e1ln\u00ed adipozity.<\/li>\n<li><strong>Antilipogenn\u00ed aktivita<\/strong> \u2014 Krom\u011b stimulace mobilizace tuk\u016f fragment HGH 176-191 potla\u010duje expresi lipogenn\u00edch gen\u016f v modelech v\u00fdzkumu adipocyt\u016f \u2014 sni\u017euje rychlost nov\u00e9ho ukl\u00e1d\u00e1n\u00ed tuk\u016f soub\u011b\u017en\u011b se zvy\u0161ov\u00e1n\u00edm jejich mobilizace. Tyto dva efekty vytv\u00e1\u0159ej\u00ed \u010dist\u00fd sign\u00e1l negativn\u00ed tukov\u00e9 bilance v tukov\u00e9 tk\u00e1ni.<\/li>\n<\/ul>\n<p>Vlastnost odd\u011blen\u00ed struktury a funkce je hlavn\u00edm v\u011bdeck\u00fdm d\u016fvodem, pro\u010d fragment HGH 176-191 z\u016fst\u00e1v\u00e1 p\u0159edm\u011btem aktivn\u00edho v\u00fdzkumu, p\u0159esto\u017ee nikdy nedos\u00e1hl regula\u010dn\u00edho schv\u00e1len\u00ed jako samostatn\u00fd terapeutik. Je u\u017eite\u010dn\u00fdm n\u00e1strojem pro v\u00fdzkumn\u00edky, kte\u0159\u00ed cht\u011bj\u00ed studovat lipolytick\u00e9 \u00fa\u010dinky HGH nez\u00e1visle na jeho r\u016fst-podporuj\u00edc\u00edch efektech \u2014 odd\u011blen\u00ed, kter\u00e9 nelze dos\u00e1hnout s pln\u011b dlouh\u00fdm HGH nebo s GH sekretagogy, kter\u00e9 spou\u0161t\u00ed uvol\u0148ov\u00e1n\u00ed endogenn\u00edho pln\u011b dlouh\u00e9ho GH. Plazmatick\u00fd polo\u010das je kr\u00e1tk\u00fd (~30 minut); subkut\u00e1nn\u00ed pod\u00e1n\u00ed je standardn\u00ed v\u00fdzkumnou cestou.<\/p>\n<h2>Publikovan\u00e9 v\u00fdzkumn\u00e9 aplikace<\/h2>\n<p>Fragment HGH 176-191 se pou\u017e\u00edv\u00e1 v laboratorn\u00edm v\u00fdzkumu ke zkoum\u00e1n\u00ed:<\/p>\n<ul>\n<li><strong>Farmakologie lipol\u00fdzy adipocyt\u016f<\/strong> \u2014 charakterizace izolovan\u00fdch lipolytick\u00fdch mechanism\u016f, studie interakce s beta-3 adrenergn\u00edmi receptory, aktivace hormon-senzitivn\u00ed lip\u00e1zy, kinetika mobilizace mastn\u00fdch kyselin<\/li>\n<li><strong>V\u00fdzkum obezity a t\u011blesn\u00e9ho slo\u017een\u00ed<\/strong> \u2014 preklinick\u00e9 modely DIO u hlodavc\u016f, t\u011blesn\u00e9 slo\u017een\u00ed (DEXA\/MRI), \u00fa\u010dinky na region\u00e1ln\u00ed tukov\u00e9 tk\u00e1n\u011b (viscer\u00e1ln\u00ed vs. subkut\u00e1nn\u00ed), v\u00fdzkumn\u00e9 n\u00e1vrhy lipol\u00fdzy bez z\u00e1m\u011bny r\u016fstov\u00e9 osy<\/li>\n<li><strong>V\u00fdzkum struktury a funkce HGH<\/strong> \u2014 mechanistick\u00e9 rozli\u0161en\u00ed r\u016fstov\u011b podporuj\u00edc\u00edch a lipolytick\u00fdch dom\u00e9n v r\u00e1mci nativn\u00edho HGH; HGH Fragment 176-191 jako kanonick\u00fd n\u00e1stroj pouze pro lipol\u00fdzu, s <a href=\"https:\/\/medsbase.com\/cs\/hgh-191aa\/\">HGH 191AA<\/a> jako kompar\u00e1tor pln\u00e9 aktivity<\/li>\n<li><strong>V\u00fdzkum lipogenn\u00ed genov\u00e9 exprese<\/strong> \u2014 diferenciace adipocyt\u016f, tvorba lipidov\u00fdch kap\u00e9nek, interakce drah PPAR\u03b3 a SREBP-1<\/li>\n<li><strong>V\u00fdzkum viscer\u00e1ln\u00ed obezity<\/strong> \u2014 p\u0159\u00edm\u00e9 srovn\u00e1n\u00ed s <a href=\"https:\/\/medsbase.com\/cs\/tesamorelin\/\">Tesamorelin<\/a> jako v\u00fdzkumn\u00fd n\u00e1stroj pro redukci viscer\u00e1ln\u00edho tuku prost\u0159ednictv\u00edm osy GHRH; publikovan\u00fd z\u00e1jem o rozli\u0161en\u00ed mechanism\u016f \u00fabytku viscer\u00e1ln\u00edho tuku z\u00e1visl\u00fdch a nez\u00e1visl\u00fdch na receptoru GH<\/li>\n<li><strong>V\u00fdzkum gluk\u00f3zov\u00e9 homeost\u00e1zy<\/strong> \u2014 na rozd\u00edl od pln\u00e9 d\u00e9lky HGH, HGH Fragment 176-191 nevyvol\u00e1v\u00e1 inzulinov\u011b kontraregula\u010dn\u00ed efekty pozorovan\u00e9 u mate\u0159sk\u00e9ho HGH; publikovan\u00fd v\u00fdzkum vyu\u017e\u00edv\u00e1 tento rozd\u00edl k rozli\u0161en\u00ed p\u0159\u00edm\u00fdch glykemick\u00fdch \u00fa\u010dink\u016f GH<\/li>\n<li><strong>Srovn\u00e1vac\u00ed v\u00fdzkum osy HGH<\/strong> \u2014 benchmarkov\u00e1n\u00ed v\u016f\u010di <a href=\"https:\/\/medsbase.com\/cs\/hgh-191aa\/\">HGH 191AA<\/a> (pln\u00e1 d\u00e9lka mate\u0159sk\u00e9 molekuly), <a href=\"https:\/\/medsbase.com\/cs\/tesamorelin\/\">Tesamorelin<\/a> (analog GHRH pro viscer\u00e1ln\u00ed tuk), a <a href=\"https:\/\/medsbase.com\/cs\/sermorelin\/\">Sermorelin<\/a> \/ <a href=\"https:\/\/medsbase.com\/cs\/cjc-1295-with-dac\/\">CJC-1295<\/a> (stimul\u00e1tory osy GHRH).<\/li>\n<\/ul>\n<p>Pro \u0161ir\u0161\u00ed kontext o za\u0159azen\u00ed HGH Fragmentu 176-191 v r\u00e1mci v\u00fdzkumu r\u016fstov\u00e9 osy a tukov\u00e9 tk\u00e1n\u011b viz <a href=\"https:\/\/medsbase.com\/cs\/hgh-191aa\/\">HGH 191AA<\/a> jako pln\u011b dlouh\u00fd mate\u0159sk\u00fd peptid, <a href=\"https:\/\/medsbase.com\/cs\/tesamorelin\/\">Tesamorelin<\/a> pro p\u0159\u00edstup k viscer\u00e1ln\u00ed obezit\u011b prost\u0159ednictv\u00edm osy GHRH a <a href=\"https:\/\/medsbase.com\/cs\/sermorelin\/\">Sermorelin<\/a> + <a href=\"https:\/\/medsbase.com\/cs\/cjc-1295-with-dac\/\">CJC-1295 with DAC<\/a> pro v\u00fdzkum endogenn\u00edch pulz\u016f GH. Prohl\u00e9dn\u011bte si cel\u00fd <a href=\"https:\/\/medsbase.com\/cs\/peptides\/\">katalog v\u00fdzkumn\u00fdch peptid\u016f<\/a> pro p\u0159\u00edbuzn\u00e9 slou\u010deniny.<\/p>\n<h2>Dostupn\u00e9 s\u00edly a koncentrace<\/h2>\n<p>MedsBase nab\u00edz\u00ed HGH Fragment 176-191 ve t\u0159ech lyofilizovan\u00fdch velikostech vialek kalibrovan\u00fdch na typick\u00e9 d\u00e9lky v\u00fdzkumn\u00fdch protokol\u016f. Ka\u017ed\u00e1 s\u00edla je dostupn\u00e1 v balen\u00ed po 10 nebo 20 vialk\u00e1ch s \u00fapln\u00fdm n\u00e1vodem na rekonstituci:<\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">S\u00edla vialky<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Typick\u00fd v\u00fdzkumn\u00fd p\u0159\u00edpad u\u017eit\u00ed<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Velikosti balen\u00ed<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>5 mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Kr\u00e1tk\u00e9 v\u00fdzkumn\u00e9 protokoly, pilotn\u00ed d\u00e1vkov\u00e1n\u00ed, studie lipol\u00fdzy v jedn\u00e9 kohort\u011b<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10 nebo 20 vialek<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>10 mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Standardn\u00ed v\u00fdzkumn\u00e1 s\u00edla, v\u00edcedenn\u00ed protokoly<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10 nebo 20 vialek<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>15 mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Protokoly pro dlouhodob\u00e9 cykly, nejni\u017e\u0161\u00ed cena za mg, studie s v\u00edce kohortami<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10 nebo 20 vialek<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>V\u0161echny t\u0159i s\u00edly maj\u00ed stejnou chemickou formu (lyofilizovan\u00fd pr\u00e1\u0161ek, \u010distota HPLC 99%+). Vysokod\u00e1vkov\u00e9 lahvi\u010dky vy\u017eaduj\u00ed men\u0161\u00ed objemy rekonstituce na jednotku d\u00e1vky, co\u017e je u\u017eite\u010dn\u00e9, kdy\u017e v\u00fdzkumn\u00edci cht\u011bj\u00ed minimalizovat objem injekce v protokolech pro hlodavce.<\/p>\n<h2>Srovn\u00e1n\u00ed \u2014 HGH Fragment 176-191 vs HGH 191AA<\/h2>\n<p>HGH Fragment 176-191 a <a href=\"https:\/\/medsbase.com\/cs\/hgh-191aa\/\">HGH 191AA<\/a> jsou struktur\u00e1ln\u011b-funk\u010dn\u011b odd\u011blen\u00fd p\u00e1r \u2014 fragment je doslova kusem pln\u011b dlouh\u00e9ho mate\u0159sk\u00e9ho peptidu. Jejich srovn\u00e1n\u00ed izoluje aktivitu vazby na GH-receptor (p\u0159\u00edtomnou u pln\u00e9 d\u00e9lky, nep\u0159\u00edtomnou u fragmentu) od lipolytick\u00e9 aktivity (p\u0159\u00edtomn\u00e9 u obou). Toto srovn\u00e1n\u00ed pat\u0159\u00ed k nej\u010dist\u0161\u00edm mechanistick\u00fdm rozbor\u016fm v sou\u010dasn\u00e9m v\u00fdzkumu r\u016fstov\u00e9 osy.<\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Krit\u00e9rium<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">HGH Fragment 176-191<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">HGH 191AA (pln\u00e1 d\u00e9lka)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>D\u00e9lka<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">16 aminokyselin (~1,8 kDa)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">191 aminokyselin (~22 kDa)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Vazba na GH receptor<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Ne (vazebn\u00e1 dom\u00e9na je N-termin\u00e1ln\u00ed)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Ano (pln\u011b dlouh\u00e1 molekula)<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Indukce IGF-1<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">\u017d\u00e1dn\u00e9<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">V\u00fdznamn\u00e1 jatern\u00ed indukce<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Lipolytick\u00e1 aktivita<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Ano (zachov\u00e1na)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Ano (pln\u00e1 aktivita p\u016fvodn\u00ed molekuly)<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>R\u016fstov\u00e9 \u00fa\u010dinky<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">\u017d\u00e1dn\u00e9<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">V\u00fdznamn\u00e9 (kanonick\u00fd anabolick\u00fd peptid)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Inzulinov\u011b kontraregula\u010dn\u00ed \u00fa\u010dinek<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Ne<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Ano (p\u0159echodn\u00e1 inzulinov\u00e1 rezistence)<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Polo\u010das v plazm\u011b<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">~30 minut<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">~3\u20135 hodin<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Schv\u00e1len\u00e9 klinick\u00e9 pou\u017eit\u00ed<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">\u017d\u00e1dn\u00e9<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">V\u00edce indikac\u00ed (Genotropin, Humatrope, atd.)<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Typick\u00e1 v\u00fdzkumn\u00e1 d\u00e1vka<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">200\u2013500 mcg, 1\u20133x denn\u011b<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">1\u20138 IU na d\u00e1vku<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Pro v\u00fdzkum zam\u011b\u0159en\u00fd na izolovanou farmakologii lipol\u00fdzy bez vlivu r\u016fstov\u00fdch a metabolick\u00fdch \u00fa\u010dink\u016f zprost\u0159edkovan\u00fdch receptorem r\u016fstov\u00e9ho hormonu je HGH Fragment 176-191 kanonick\u00fdm n\u00e1strojem pro \u201cpouze lipol\u00fdzu\u201d. Pro v\u00fdzkum zkoumaj\u00edc\u00ed celou osu GH\/IGF nebo porovn\u00e1vaj\u00edc\u00ed s endogenn\u00ed sekrec\u00ed GH vyvolanou sekretagogy, <a href=\"https:\/\/medsbase.com\/cs\/hgh-191aa\/\">HGH 191AA<\/a> je vhodnou referenc\u00ed pln\u00e9 d\u00e9lky. Mnoho publikovan\u00fdch v\u00fdzkumn\u00fdch design\u016f pou\u017e\u00edv\u00e1 oba paraleln\u011b k rozli\u0161en\u00ed, kter\u00e9 \u00fa\u010dinky HGH z\u00e1vis\u00ed na signalizaci p\u0159es receptor GH a kter\u00e9 vypl\u00fdvaj\u00ed z C-termin\u00e1ln\u00edho lipolytick\u00e9ho mechanismu.<\/p>\n<h2>Skladov\u00e1n\u00ed a rekonstituce<\/h2>\n<p><strong>P\u0159ed rekonstituci:<\/strong> lyofilizovan\u00e9 lahvi\u010dky skladujte v chladni\u010dce p\u0159i 2\u20138 \u00b0C v p\u016fvodn\u00edm obalu pro kr\u00e1tkodob\u00e9 pou\u017eit\u00ed. Pro dlouhodob\u00e9 skladov\u00e1n\u00ed neotev\u0159en\u00fdch lahvi\u010dek zmrazte p\u0159i \u221220 \u00b0C. Lyofilizovan\u00fd HGH Fragment 176-191 je stabiln\u00ed v chladni\u010dce a\u017e 24 m\u011bs\u00edc\u016f a p\u0159i \u221220 \u00b0C a\u017e 36 m\u011bs\u00edc\u016f. Vyhn\u011bte se cykl\u016fm zmrazov\u00e1n\u00ed a rozmrazov\u00e1n\u00ed lyofilizovan\u00e9ho pr\u00e1\u0161ku. Stejn\u011b jako u jin\u00fdch peptid\u016f s disulfidov\u00fdmi m\u016fstky z\u00e1vis\u00ed aktivita fragmentu na neporu\u0161en\u00e9 vazb\u011b Cys182\u2013Cys189 (\u010d\u00edslov\u00e1n\u00ed fragmentu Cys7\u2013Cys14) \u2014 manipulace, kter\u00e1 naru\u0161\u00ed disulfid, sn\u00ed\u017e\u00ed aktivitu.<\/p>\n<p><strong>Postup rekonstituce:<\/strong> injektujte bakteriostatickou vodu po stran\u011b lahvi\u010dky s peptidem (ne p\u0159\u00edmo na lyofilizovan\u00fd kol\u00e1\u010d). Pro lahvi\u010dku 5 mg, 2,0 ml bakteriostatick\u00e9 vody vytvo\u0159\u00ed pracovn\u00ed koncentraci 2,5 mg\/ml \u2014 0,04 ml pod\u00e1 100 mcg; 0,1 ml pod\u00e1 250 mcg; 0,2 ml pod\u00e1 500 mcg. Jemn\u011b zakru\u017ete \u2014 ned\u011blejte <strong>ne<\/strong> net\u0159epejte \u2013 a nechte 2\u20135 minut pro \u00fapln\u00e9 rozpu\u0161t\u011bn\u00ed. Spr\u00e1vn\u011b rekonstituovan\u00fd roztok by m\u011bl b\u00fdt \u010dir\u00fd a bezbarv\u00fd.<\/p>\n<p><strong>Po rekonstituci:<\/strong> skladujte v chladni\u010dce p\u0159i 2\u20138 \u00b0C a pou\u017eijte do 30 dn\u016f pro optim\u00e1ln\u00ed stabilitu. Nepou\u017e\u00edvejte zmrazen\u00ed rekonstituovan\u00e9ho roztoku \u2014 cykly zmrazov\u00e1n\u00ed a rozmrazov\u00e1n\u00ed naru\u0161uj\u00ed integritu peptidu a mohou po\u0161kodit disulfidovou vazbu. Zlikvidujte jakoukoli lahvi\u010dku s projevy z\u00e1kalu, sra\u017eenin nebo zm\u011bny barvy.<\/p>\n<h2 id=\"faqs\">\u010casto kladen\u00e9 dotazy<\/h2>\n<h3>K \u010demu se HGH Fragment 176-191 pou\u017e\u00edv\u00e1 ve v\u00fdzkumu?<\/h3>\n<p>HGH Fragment 176-191 se pou\u017e\u00edv\u00e1 v laboratorn\u00edm v\u00fdzkumu zam\u011b\u0159en\u00e9m na izolovanou farmakologii lipol\u00fdzy adipocyt\u016f, regulaci obezity a t\u011blesn\u00e9ho slo\u017een\u00ed bez vlivu r\u016fstov\u00e9 osy, anal\u00fdzu struktury a funkce HGH, regulaci genov\u00e9 exprese lipogeneze, \u00fa\u010dinky na region\u00e1ln\u00ed tukov\u00e9 tk\u00e1n\u011b a srovn\u00e1vac\u00ed v\u00fdzkumn\u00e9 designy porovn\u00e1vaj\u00edc\u00ed osu GH s lipol\u00fdzou. Je to kanonick\u00fd v\u00fdzkumn\u00fd peptid pro \u201cpouze lipol\u00fdzu\u201d odvozen\u00fd od nativn\u00edho HGH. V\u00fdzkumn\u00fd HGH Fragment 176-191 prod\u00e1van\u00fd zde je <strong>ne<\/strong> schv\u00e1len\u00fd FDA a je dod\u00e1v\u00e1n v\u00fdhradn\u011b pro laboratorn\u00ed v\u00fdzkumn\u00e9 \u00fa\u010dely.<\/p>\n<h3>Jak se HGH Fragment 176-191 li\u0161\u00ed od HGH 191AA?<\/h3>\n<p>HGH Fragment 176-191 m\u00e1 jen 16 aminokyselin \u2014 C-termin\u00e1ln\u00ed \u010d\u00e1st pln\u00e9 d\u00e9lky HGH s 191 aminokyselinami. Fragment postr\u00e1d\u00e1 dom\u00e9nu vazby na receptor GH (kter\u00e1 se nach\u00e1z\u00ed v N-termin\u00e1ln\u00ed \u010d\u00e1sti mate\u0159sk\u00e9 molekuly), tak\u017ee se NEv\u00e1\u017ee na GHR, NEindukuje IGF-1 a NEvyvol\u00e1v\u00e1 \u017e\u00e1dn\u00e9 r\u016fstov\u00e9 nebo inzulinov\u00e9 \u00fa\u010dinky pln\u00e9ho HGH. Zachov\u00e1v\u00e1 pouze lipolytickou a antilipogenn\u00ed aktivitu. <a href=\"https:\/\/medsbase.com\/cs\/hgh-191aa\/\">HGH 191AA<\/a> je pln\u00e1 mate\u0159sk\u00e1 molekula s lipolytickou i r\u016fstovou aktivitou.<\/p>\n<h3>Jak se HGH Fragment 176-191 li\u0161\u00ed od AOD9604?<\/h3>\n<p>Jsou <strong>odli\u0161n\u00e9 slou\u010deniny<\/strong> kter\u00e9 jsou \u010dasto zam\u011b\u0148ov\u00e1ny. HGH Fragment 176-191 (CAS 66004-57-7) je nemodifikovan\u00fd C-termin\u00e1ln\u00ed fragment p\u0159irozen\u00e9ho HGH. AOD9604 (CAS 221231-10-9) je modifikovan\u00fd analog vyvinut\u00fd spole\u010dnost\u00ed Metabolic Pharmaceuticals \u2014 konkr\u00e9tn\u011b AOD9604 p\u0159id\u00e1v\u00e1 N-termin\u00e1ln\u00ed tyrosinovou substituci vytv\u00e1\u0159ej\u00edc\u00ed Tyr-HGH 177-191, s upraven\u00fdmi zm\u011bnami disulfidov\u00e9ho m\u016fstku pro lep\u0161\u00ed stabilitu a v\u00fdzkum or\u00e1ln\u00ed biologick\u00e9 dostupnosti. Tyto dv\u011b slou\u010deniny maj\u00ed souvisej\u00edc\u00ed, ale odli\u0161nou farmakologii. Tento produkt je nemodifikovan\u00fd fragment 176-191, nikoli AOD9604.<\/p>\n<h3>Jak\u00e1 je typick\u00e1 v\u00fdzkumn\u00e1 d\u00e1vka HGH Fragmentu 176-191?<\/h3>\n<p>Publikovan\u00e9 preklinick\u00e9 protokoly obvykle pou\u017e\u00edvaj\u00ed 200\u2013500 mcg na pod\u00e1n\u00ed, aplikov\u00e1no subkut\u00e1nn\u011b 1\u20133kr\u00e1t denn\u011b po dobu 4\u201312 t\u00fddn\u016f v\u00fdzkumn\u00fdch cykl\u016f. 5 mg lahvi\u010dka rekonstituovan\u00e1 s 2,0 mL bakteriostatick\u00e9 vody poskytne koncentraci 2,5 mg\/mL \u2014 0,04 mL odpov\u00edd\u00e1 100 mcg, 0,2 mL odpov\u00edd\u00e1 500 mcg.<\/p>\n<h3>Je HGH Fragment 176-191 schv\u00e1len FDA?<\/h3>\n<p>Ne. HGH Fragment 176-191 nen\u00ed schv\u00e1len FDA, EMA, MHRA ani \u017e\u00e1dn\u00fdm jin\u00fdm v\u00fdznamn\u00fdm regul\u00e1torem pro terapeutick\u00e9 pou\u017eit\u00ed u lid\u00ed. Souvisej\u00edc\u00ed slou\u010denina AOD9604 byla zkoum\u00e1na v klinick\u00fdch studi\u00edch pro obezitu, ale nedos\u00e1hla regula\u010dn\u00edho schv\u00e1len\u00ed. Ve\u0161ker\u00fd HGH Fragment 176-191 prod\u00e1van\u00fd dodavateli pouze pro v\u00fdzkumn\u00e9 \u00fa\u010dely je ur\u010den pro laboratorn\u00ed v\u00fdzkum a nem\u011bl by b\u00fdt pod\u00e1v\u00e1n lidem.<\/p>\n<h3>Jak by m\u011bl b\u00fdt HGH Fragment 176-191 skladov\u00e1n?<\/h3>\n<p>Lyofilizovan\u00e9 lahvi\u010dky: chlazeno p\u0159i 2\u20138 \u00b0C pro kr\u00e1tkodob\u00e9 pracovn\u00ed z\u00e1soby, nebo \u221220 \u00b0C pro dlouhodob\u00e9 skladov\u00e1n\u00ed neotev\u0159en\u00fdch lahvi\u010dek. Rekonstituovan\u00fd roztok: chlazeno p\u0159i 2\u20138 \u00b0C, pou\u017e\u00edt do 30 dn\u016f. Nefreezujte rekonstituovan\u00fd roztok \u2014 cykly zmrazen\u00ed a rozmrazen\u00ed degraduj\u00ed peptid a mohou naru\u0161it esenci\u00e1ln\u00ed disulfidov\u00fd m\u016fstek Cys182\u2013Cys189. Chra\u0148te p\u0159ed p\u0159\u00edm\u00fdm sv\u011btlem za v\u0161ech okolnost\u00ed.<\/p>\n<h3>Jak rekonstituovat HGH Fragment 176-191?<\/h3>\n<p>Postupujte podle v\u00fd\u0161e uveden\u00e9ho rekonstitu\u010dn\u00edho postupu. P\u0159idejte bakteriostatickou vodu po st\u011bn\u011b lahvi\u010dky (ne p\u0159\u00edmo na lyofilizovan\u00fd pr\u00e1\u0161ek), jemn\u011b prot\u0159epejte a nechte 2\u20135 minut pro \u00fapln\u00e9 rozpu\u0161t\u011bn\u00ed. Ne <strong>ne<\/strong> Prot\u0159epejte lahvi\u010dku \u2014 intenzivn\u00ed m\u00edch\u00e1n\u00ed m\u016f\u017ee naru\u0161it disulfidovou vazbu. Spr\u00e1vn\u011b rekonstituovan\u00fd roztok je \u010dir\u00fd a bezbarv\u00fd. Pro lahvi\u010dku 5 mg + 2,0 mL \u0159edidla je pracovn\u00ed koncentrace 2,5 mg\/mL.<\/p>\n<h3>Jak\u00e9 s\u00edly nab\u00edz\u00ed MedsBase?<\/h3>\n<p>MedsBase nab\u00edz\u00ed HGH Fragment 176-191 v lyofilizovan\u00fdch lahvi\u010dk\u00e1ch 5 mg, 10 mg a 15 mg. Ka\u017ed\u00e1 s\u00edla je dostupn\u00e1 v balen\u00ed po 10 nebo 20 lahvi\u010dk\u00e1ch. V\u0161echny lahvi\u010dky jsou dod\u00e1v\u00e1ny s \u010distotou 99 %+ HPLC a certifik\u00e1tem anal\u00fdzy na vy\u017e\u00e1d\u00e1n\u00ed.<\/p>\n<h3>Pro\u010d HGH Fragment 176-191 neovliv\u0148uje IGF-1?<\/h3>\n<p>Povrch vazby na receptor GH p\u0159irozen\u00e9ho lidsk\u00e9ho r\u016fstov\u00e9ho hormonu se nach\u00e1z\u00ed v N-termin\u00e1ln\u00ed \u010d\u00e1sti 191-aminokyselinov\u00e9 molekuly, nikoli v C-termin\u00e1ln\u00ed oblasti 176\u2013191. Proto\u017ee fragment postr\u00e1d\u00e1 vazebnou dom\u00e9nu receptoru, nem\u016f\u017ee aktivovat receptor GH; bez aktivace GHR nen\u00ed spu\u0161t\u011bna n\u00e1sledn\u00e1 signaliza\u010dn\u00ed kask\u00e1da JAK2\/STAT5, kter\u00e1 \u0159\u00edd\u00ed transkripci jatern\u00edho IGF-1. Toto struktur\u00e1ln\u011b-funk\u010dn\u00ed odd\u011blen\u00ed je hlavn\u00edm v\u011bdeck\u00fdm d\u016fvodem, pro\u010d fragment p\u0159itahuje v\u00fdzkumn\u00fd z\u00e1jem jako n\u00e1stroj izoluj\u00edc\u00ed lipol\u00fdzu.<\/p>\n<h3>Odkud poch\u00e1z\u00ed lipolytick\u00e1 aktivita, pokud ne z vazby na receptor GH?<\/h3>\n<p>P\u0159esn\u00fd molekul\u00e1rn\u00ed c\u00edl lipolytick\u00e9ho \u00fa\u010dinku HGH Fragmentu 176-191 z\u016fst\u00e1v\u00e1 aktivn\u00ed v\u00fdzkumnou ot\u00e1zkou. Navrhovan\u00e9 mechanismy zahrnuj\u00ed p\u0159\u00edmou interakci s beta-3 adrenergn\u00edmi receptory adipocyt\u016f, modulaci aktivity hormon-senzitivn\u00ed lip\u00e1zy a zm\u011bn\u011bnou kinetiku oxidace mastn\u00fdch kyselin v tukov\u00e9 tk\u00e1ni. Fragment tak\u00e9 potla\u010duje expresi lipogenn\u00edch gen\u016f, co\u017e nazna\u010duje, \u017ee p\u016fsob\u00ed na v\u00edce adipocyt-specifick\u00fdch drah sou\u010dasn\u011b. Publikovan\u00fd v\u00fdzkum st\u00e1le charakterizuje p\u0159esn\u00fd receptor nebo c\u00edlov\u00e9 vazebn\u00e9 m\u00edsto.<\/p>\n<h3>Zp\u016fsobuje HGH Fragment 176-191 vedlej\u0161\u00ed \u00fa\u010dinky ve v\u00fdzkumu?<\/h3>\n<p>Publikovan\u00e9 preklinick\u00e9 v\u00fdzkumy dokumentuj\u00ed v\u00fdrazn\u011b \u010dist\u00fd bezpe\u010dnostn\u00ed profil p\u0159i typick\u00fdch v\u00fdzkumn\u00fdch d\u00e1vk\u00e1ch, p\u0159i\u010dem\u017e hlavn\u00edm c\u00edlov\u00fdm \u00fa\u010dinkem je lipol\u00fdza. Absence vazby na GH-receptor znamen\u00e1, \u017ee nejsou p\u0159\u00edtomny \u017e\u00e1dn\u00e9 vedlej\u0161\u00ed \u00fa\u010dinky GH-osy pozorovan\u00e9 u pln\u00e9 d\u00e9lky HGH (p\u0159echodn\u00e1 inzul\u00ednov\u00e1 rezistence, nepohodl\u00ed kloub\u016f, retence sod\u00edku, mitogenn\u00ed signalizace). Dlouhodob\u00e9 \u00fadaje o bezpe\u010dnosti u lid\u00ed jsou omezen\u00e9, proto\u017ee nemodifikovan\u00fd fragment nepro\u0161el modern\u00edm regula\u010dn\u00edm p\u0159ezkumem (a\u010dkoli souvisej\u00edc\u00ed AOD9604 byl podrobn\u011bji zkoum\u00e1n v klinick\u00fdch studi\u00edch).<\/p>\n<h3>Jak\u00fd je polo\u010das rozpadu HGH Fragmentu 176-191?<\/h3>\n<p>V preklinick\u00e9m v\u00fdzkumu m\u00e1 HGH Fragment 176-191 plazmatick\u00fd polo\u010das rozpadu p\u0159ibli\u017en\u011b 30 minut po subkut\u00e1nn\u00edm pod\u00e1n\u00ed \u2013 krat\u0161\u00ed ne\u017e pln\u00e1 d\u00e9lka HGH (~3\u20135 hodin) kv\u016fli men\u0161\u00ed molekul\u00e1rn\u00ed velikosti a absenci modifikac\u00ed v\u00e1zaj\u00edc\u00edch albumin. Kr\u00e1tk\u00fd polo\u010das rozpadu znamen\u00e1, \u017ee typick\u00e9 v\u00fdzkumn\u00e9 protokoly pou\u017e\u00edvaj\u00ed v\u00edce denn\u00edch pod\u00e1n\u00ed nebo v\u00fdzkumn\u00e9 formulace s kontinu\u00e1ln\u00edm uvol\u0148ov\u00e1n\u00edm pro pr\u00e1ci s trvalou expozic\u00ed.<\/p>\n<h3>Jak dlouho trv\u00e1, ne\u017e se projev\u00ed \u00fa\u010dinky HGH Fragmentu 176-191 v preklinick\u00e9m v\u00fdzkumu?<\/h3>\n<p>Akutn\u00ed \u00fa\u010dinky na lipol\u00fdzu adipocyt\u016f a mobilizaci mastn\u00fdch kyselin jsou detekovateln\u00e9 b\u011bhem n\u011bkolika hodin po pod\u00e1n\u00ed. \u00da\u010dinky na slo\u017een\u00ed t\u011bla u DIO model\u016f hlodavc\u016f se obvykle st\u00e1vaj\u00ed statisticky v\u00fdznamn\u00fdmi po 2\u20134 t\u00fddnech pravideln\u00e9ho d\u00e1vkov\u00e1n\u00ed a d\u00e1le se zvy\u0161uj\u00ed po 8\u201312 t\u00fddnech kontinu\u00e1ln\u00edho pod\u00e1v\u00e1n\u00ed. Kinetika je podobn\u00e1 jako u jin\u00fdch v\u00fdzkumn\u00fdch slou\u010denin c\u00edlen\u00fdch na tukovou tk\u00e1\u0148.<\/p>\n<h3>Mohu si objednat HGH Fragment 176-191 pro mezin\u00e1rodn\u00ed p\u0159epravu?<\/h3>\n<p>Ano. MedsBase zas\u00edl\u00e1 HGH Fragment 176-191 po cel\u00e9m sv\u011bt\u011b z na\u0161\u00ed specializovan\u00e9 s\u00edt\u011b pro p\u0159epravu peptid\u016f. Objedn\u00e1vky obsahuj\u00edc\u00ed pouze peptidy se kvalifikuj\u00ed pro na\u0161i samostatnou slu\u017ebu p\u0159epravy peptid\u016f. V\u0161echny objedn\u00e1vky jsou odes\u00edl\u00e1ny v teplotn\u011b kontrolovan\u00e9m balen\u00ed s pln\u00fdm sledov\u00e1n\u00edm a jsou pokryty na\u0161\u00edm <a href=\"https:\/\/medsbase.com\/cs\/medsbase-re-shipment-assurance-policy\/\">Z\u00e1rukou op\u011btovn\u00e9ho odesl\u00e1n\u00ed<\/a>.<\/p>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h2>Dal\u0161\u00ed peptidy pro v\u00fdzkum tukov\u00e9 tk\u00e1n\u011b, r\u016fstov\u00e9 osy a slo\u017een\u00ed t\u011bla<\/h2>\n<ul>\n<li><a href=\"\/cs\/hgh-191aa\/\"><strong>HGH 191AA<\/strong><\/a> \u2014 Pln\u00e1 d\u00e9lka rekombinantn\u00edho lidsk\u00e9ho r\u016fstov\u00e9ho hormonu \u2014 mate\u0159sk\u00e1 molekula tohoto fragmentu<\/li>\n<li><a href=\"\/cs\/tesamorelin\/\"><strong>Tesamorelin<\/strong><\/a> \u2014 Analog GHRH \u2014 v\u00fdzkum viscer\u00e1ln\u00ed tukov\u00e9 tk\u00e1n\u011b; schv\u00e1leno FDA pro HIV-asociovanou lipodystrofii<\/li>\n<li><a href=\"\/cs\/cjc-1295-with-dac\/\"><strong>CJC-1295 with DAC<\/strong><\/a> \u2014 Dlouhodob\u011b p\u016fsob\u00edc\u00ed analog GHRH \u2014 v\u00fdzkum endogenn\u00edch pulz\u016f GH<\/li>\n<li><a href=\"\/cs\/sermorelin\/\"><strong>Sermorelin<\/strong><\/a> \u2014 Analog GHRH(1-29) \u2014 v\u00fdzkum kr\u00e1tkodob\u011b p\u016fsob\u00edc\u00edho GHRH<\/li>\n<li><a href=\"\/cs\/ipamorelin\/\"><strong>Ipamorelin<\/strong><\/a> \u2014 Selektivn\u00ed sekretagog r\u016fstov\u00e9ho hormonu \u2014 v\u00fdzkum \u010dist\u00fdch pulz\u016f GH<\/li>\n<\/ul>\n<p><!-- medsbase-peptide-guide-cta --><\/p>\n<h2>Dal\u0161\u00ed \u010dten\u00ed<\/h2>\n<div style=\"background: #f4f8fb; border-left: 4px solid #2c7cb0; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<p style=\"margin: 0 0 8px 0;\"><strong>\ud83d\udcd6 Prozkoumejte v\u00fdzkumnou krajinu osy HGH<\/strong><\/p>\n<p style=\"margin: 0;\">Prohl\u00e9dn\u011bte si celou <a href=\"https:\/\/medsbase.com\/cs\/peptides\/\"><strong>katalog v\u00fdzkumn\u00fdch peptid\u016f<\/strong><\/a>, se souvisej\u00edc\u00edmi slou\u010deninami r\u016fstov\u00e9 osy v\u010detn\u011b <a href=\"https:\/\/medsbase.com\/cs\/hgh-191aa\/\">HGH 191AA<\/a> (pln\u00e1 d\u00e9lka mate\u0159sk\u00e9 molekuly), <a href=\"https:\/\/medsbase.com\/cs\/tesamorelin\/\">Tesamorelin<\/a> (analog GHRH pro viscer\u00e1ln\u00ed adipozitu), <a href=\"https:\/\/medsbase.com\/cs\/sermorelin\/\">Sermorelin<\/a> a <a href=\"https:\/\/medsbase.com\/cs\/cjc-1295-with-dac\/\">CJC-1295 with DAC<\/a> pro v\u00fdzkum endogenn\u00edch pulz\u016f.<\/p>\n<\/div>\n<p><!-- pep-seo-v1 --><\/p>","protected":false},"excerpt":{"rendered":"<p>\u2705 16-aa C-koncov\u00fd fragment lidsk\u00e9ho r\u016fstov\u00e9ho hormonu<br \/>\n\u2705 Zachov\u00e1v\u00e1 lipolytickou aktivitu bez vazby na GH-receptor<br \/>\n\u2705 \u017d\u00e1dn\u00e1 indukce IGF-1 nebo r\u016fstov\u00e9 \u00fa\u010dinky<br \/>\n\u2705 \u010cist\u011b lipolytick\u00fd v\u00fdzkumn\u00fd n\u00e1stroj (odli\u0161n\u00fd od AOD9604)<br \/>\n\u2705 \u226599% HPLC \u010distota, COA na vy\u017e\u00e1d\u00e1n\u00ed<\/p>\n<p><strong>HGH Fragment 176-191<\/strong> obsahuje syntetickou peptidovou slou\u010deninu.<\/p>","protected":false},"featured_media":70959,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[5426],"product_tag":[6288,6289,5441],"class_list":{"0":"post-70781","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-peptides","7":"product_tag-hgh","8":"product_tag-hgh-fragment","9":"product_tag-peptide","11":"first","12":"instock","13":"shipping-taxable","14":"purchasable","15":"product-type-variable","16":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product\/70781","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/comments?post=70781"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/media\/70959"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/media?parent=70781"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_brand?post=70781"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_cat?post=70781"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_tag?post=70781"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}